Elevated Calprotectin and Colitis: Diagnostic Implications
Elevated fecal calprotectin is a reliable indicator of intestinal inflammation but is not specific for colitis, requiring additional diagnostic evaluation to confirm the diagnosis. 1, 2
Diagnostic Value of Fecal Calprotectin
Calprotectin Thresholds and Interpretation
- Fecal calprotectin levels can be categorized as:
- Normal: <50 μg/g
- Borderline: 50-150 μg/g
- Elevated: >150 μg/g
- Highly elevated: >250 μg/g 2
Diagnostic Performance
- At a cutoff of 50 μg/g: 78% sensitivity, 57% specificity 1
- At a cutoff of 150 μg/g: 71% sensitivity, 69% specificity 1
- At a cutoff of 250 μg/g: 67% sensitivity, 73% specificity 1
Clinical Implications
- Elevated calprotectin (>150 μg/g) reliably differentiates inflammatory bowel disease (IBD) from irritable bowel syndrome (IBS) with specificity and sensitivity exceeding 85% 2
- However, elevated levels alone cannot definitively diagnose colitis without additional testing 1, 2
Relationship Between Calprotectin and Colitis
Correlation with Disease Activity
- Fecal calprotectin shows excellent correlation with endoscopic and histological activity in ulcerative colitis 3, 4
- Levels increase significantly with increasing endoscopic and histologic disease activity 3
- For ulcerative colitis, a cutoff level of 192 mg/kg identifies patients with endoscopic mucosal healing with:
- Positive predictive value: 0.71-0.65
- Negative predictive value: 0.90-0.93 3
Limitations and False Positives
- Elevated calprotectin is not specific to colitis and can be elevated in:
Diagnostic Algorithm for Evaluating Elevated Calprotectin
Initial Evaluation:
Risk Stratification Based on Calprotectin Level:
Further Diagnostic Steps:
Important Caveats and Pitfalls
- False Positives: Elevated calprotectin can occur in conditions other than colitis, including infections, medications, and malignancy 2
- Segmental Disease: Patchy or segmental inflammation may be missed during routine colonoscopy, occurring in up to 10% of IBD diagnoses 2
- Gradient Effect: Calprotectin sensitivity varies by location of inflammation, with higher sensitivity for colonic inflammation than small bowel inflammation 5
- Clinical Context: Interpretation must consider clinical symptoms, as asymptomatic patients with elevated calprotectin may have subclinical inflammation 1
Monitoring and Follow-up
- Serial monitoring of fecal calprotectin every 3-6 months is recommended in confirmed IBD 2
- Rising levels in patients with previously quiescent disease can predict clinical relapse with >85% sensitivity and specificity 2
- A cutoff of 171 mg/kg identifies histologic mucosal healing with positive predictive value of 0.75 and negative predictive value of 0.90 3
In summary, while elevated fecal calprotectin strongly suggests intestinal inflammation, endoscopic evaluation with histopathology is necessary to definitively diagnose colitis and determine its specific type and extent.